• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

修订型吸收不良性减重手术的长期结果:获益是否大于风险?

Long-Term Outcomes of Revisional Malabsorptive Bariatric Surgery: Do the Benefits Outweigh the Risk?

机构信息

Department of Surgery, Central Clinical School, Monash University, Level 6, Alfred Centre, 99 Commercial Road, 3002 VIC, Melbourne, Australia.

Oesophago-Gastric and Bariatric Surgical Unit, Department of General Surgery, The Alfred Hospital, Melbourne, 3004, Australia.

出版信息

Obes Surg. 2022 Jun;32(6):1822-1830. doi: 10.1007/s11695-022-06019-7. Epub 2022 Mar 30.

DOI:10.1007/s11695-022-06019-7
PMID:35352269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9072481/
Abstract

PURPOSE

To evaluate the long-term outcomes of revisional malabsorptive bariatric surgery.

MATERIALS AND METHODS

Malabsorptive bariatric procedures are increasingly performed in the revisional setting. We collated and analysed prospectively recorded data for all patients who underwent a revisional Biliopancreatic diversion + / - duodenal switch (BPD + / - DS) over a 17-year period.

RESULTS

We identified 102 patients who underwent a revisional BPD + / - DS. Median follow-up was 7 years (range 1-17). There were 21 (20.6%) patients permanently lost to follow-up at a median of 5 years postoperatively. Mean total weight loss since the revisional procedure of 22.7% (SD 13.4), 20.1% (SD 10.5) and 17.6% (SD 5.5) was recorded at 5, 10 and 15 years respectively. At the time of revisional surgery, 23 (22.5%) patients had diabetes and 16 (15.7%) had hypercholesterolaemia with remission of these occurring in 20 (87%) and 7 (44%) patients respectively. Nutritional deficiencies occurred in 82 (80.4%) patients, with 10 (9.8%) patients having severe deficiencies requiring periods of parenteral nutrition. Seven (6.9%) patients required limb lengthening or reversal procedures. There were 16 (15.7%) patients who experienced a complication within 30 days, including 3 (2.9%) anastomotic leaks. Surgery was required in 42 (41.2%) patients for late complications.

CONCLUSION

Revisional malabsorptive bariatric surgery induces significant long-term weight loss and comorbidity resolution. High rates of temporary and permanent attrition from follow-up are of major concern, given the high prevalence of nutritional deficiencies. These data question the long-term safety of malabsorptive bariatric procedures due to the inability to ensure compliance with nutritional supplementation and long-term follow-up requirements.

KEY POINTS

• Revisional bariatric surgery workload is increasing • Revisional malabsorptive surgery is efficacious for weight loss and comorbidity resolution • Revisional malabsorptive surgery is associated with high rates of nutritional deficiencies • Attrition from follow-up in this specific cohort of patients is of particular concern due to the risk of undiagnosed and untreated nutritional deficiencies.

摘要

目的

评估可复发性吸收不良性减重手术的长期效果。

材料与方法

吸收不良性减重手术在可复发性减重手术中越来越常见。我们收集并分析了 17 年来所有接受可复发性胆胰分流术+/-十二指肠转位术(BPD+/-DS)的患者的前瞻性记录数据。

结果

我们共纳入 102 例接受可复发性 BPD+/-DS 的患者。中位随访时间为 7 年(1-17 年)。21 例(20.6%)患者在术后 5 年时永久性失访。自可复发性手术以来,体重减轻的平均值为 22.7%(SD 13.4)、20.1%(SD 10.5)和 17.6%(SD 5.5),分别记录于术后 5、10 和 15 年。在进行可复发性手术时,23 例(22.5%)患者患有糖尿病,16 例(15.7%)患有高胆固醇血症,其中 20 例(87%)和 7 例(44%)患者的病情得到缓解。82 例(80.4%)患者出现营养缺乏,10 例(9.8%)患者出现严重缺乏,需要接受一段时间的肠外营养。7 例(6.9%)患者需要进行肢体延长或反转手术。16 例(15.7%)患者在 30 天内出现并发症,包括 3 例(2.9%)吻合口漏。42 例(41.2%)患者因迟发性并发症需要手术治疗。

结论

可复发性吸收不良性减重手术可显著减轻体重并解决合并症。临时和永久性随访流失率较高,令人严重关切,考虑到营养缺乏症的高患病率。这些数据由于无法确保遵守营养补充和长期随访要求,对吸收不良性减重手术的长期安全性提出质疑。

关键点

  1. 可复发性减重手术工作量不断增加。

  2. 可复发性吸收不良性手术对减轻体重和解决合并症有效。

  3. 可复发性吸收不良性手术与高营养缺乏率相关。

  4. 由于存在未确诊和未治疗的营养缺乏症风险,因此该特定患者队列中失访的情况尤其令人担忧。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec4/9072481/47fbd29b3e7c/11695_2022_6019_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec4/9072481/8458b3e9377d/11695_2022_6019_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec4/9072481/422c6152d9cf/11695_2022_6019_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec4/9072481/28ef9a747348/11695_2022_6019_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec4/9072481/47fbd29b3e7c/11695_2022_6019_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec4/9072481/8458b3e9377d/11695_2022_6019_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec4/9072481/422c6152d9cf/11695_2022_6019_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec4/9072481/28ef9a747348/11695_2022_6019_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec4/9072481/47fbd29b3e7c/11695_2022_6019_Fig4_HTML.jpg

相似文献

1
Long-Term Outcomes of Revisional Malabsorptive Bariatric Surgery: Do the Benefits Outweigh the Risk?修订型吸收不良性减重手术的长期结果:获益是否大于风险?
Obes Surg. 2022 Jun;32(6):1822-1830. doi: 10.1007/s11695-022-06019-7. Epub 2022 Mar 30.
2
Revisional Malabsorptive Bariatric Surgery: 29-Year Follow-up in a Brazilian Public Hospital.修订型吸收不良性减重手术:巴西公立医院 29 年随访结果。
Obes Surg. 2018 Jun;28(6):1504-1510. doi: 10.1007/s11695-017-3023-9.
3
Laparoscopic Reversal of the Biliopancreatic Diversion with Duodenal Switch: a Step by Step Video Case.腹腔镜下胆胰转流十二指肠转位术的逆转:分步视频病例
Obes Surg. 2017 Dec;27(12):3327-3329. doi: 10.1007/s11695-017-2945-6.
4
Long-term outcomes after biliopancreatic diversion with and without duodenal switch: 2-, 5-, and 10-year data.实施与未实施十二指肠转位的胆胰分流术后的长期结果:2年、5年和10年数据。
Surg Obes Relat Dis. 2016 Nov;12(9):1697-1705. doi: 10.1016/j.soard.2016.03.006. Epub 2016 Mar 9.
5
Management of Malnutrition and Hepatic Impairment After Duodenal Switch.十二指肠转位术后营养不良与肝功能损害的管理
Obes Surg. 2024 Feb;34(2):602-609. doi: 10.1007/s11695-023-07032-0. Epub 2024 Jan 5.
6
Short-term outcomes of revisional surgery after sleeve gastrectomy: a comparative analysis of re-sleeve, Roux en-Y gastric bypass, duodenal switch (Roux en-Y and single-anastomosis).袖状胃切除术后再次手术的短期疗效:再行袖状胃切除术、Roux-en-Y 胃旁路术、十二指肠转位术(Roux-en-Y 和单吻合术)的对比分析。
Surg Endosc. 2021 Aug;35(8):4644-4652. doi: 10.1007/s00464-020-07891-z. Epub 2020 Aug 11.
7
Safety of Primary Versus Revisional Biliopancreatic Diversion with Duodenal Switch in Patients with Super Obesity Using the MBSAQIP database.使用 MBSAQIP 数据库评估超级肥胖患者行原发性与翻修胆胰转流十二指肠转位术的安全性。
Obes Surg. 2022 May;32(5):1459-1465. doi: 10.1007/s11695-022-05953-w. Epub 2022 Feb 8.
8
Clinical and Metabolic Effects of Biliopancreatic Diversion Persist After Reduction of the Gastric Pouch and Elongation of the Common Alimentary Tract. Preliminary Report in a Series of Patients with a 10-Year Follow-Up.胃囊缩小及共同消化道延长后胆胰转流术的临床和代谢效应仍持续存在。对一系列患者进行10年随访的初步报告。
Obes Surg. 2017 Jun;27(6):1493-1500. doi: 10.1007/s11695-016-2479-3.
9
Revisional Surgery for Insufficient Loss or Regain of Weight After Roux-en-Y Gastric Bypass: Biliopancreatic Limb Length Matters.Roux-en-Y 胃旁路术后体重不足或反弹的再次手术:胆胰支长度很重要。
Obes Surg. 2020 Mar;30(3):804-811. doi: 10.1007/s11695-019-04348-8.
10
Revision and reversal after biliopancreatic diversion for excessive side effects or ineffective weight loss: a review of the current literature on indications and procedures.胆胰转流术后因副作用过多或减重效果不佳而进行的修正和逆转:关于适应证和手术方法的当前文献综述
Surg Obes Relat Dis. 2015 Jul-Aug;11(4):965-72. doi: 10.1016/j.soard.2015.01.015. Epub 2015 Jan 28.

引用本文的文献

1
Enhancing nutritional health and patient satisfaction five years after metabolic bariatric surgery with targeted supplementation.通过针对性补充营养,在代谢性减肥手术后五年提高营养健康水平和患者满意度。
J Transl Med. 2025 Feb 21;23(1):216. doi: 10.1186/s12967-025-06224-9.
2
Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement.代谢和减重手术后体重和肥胖相关并发症复发的治疗选择:IFSO 立场声明。
Obes Surg. 2024 Nov;34(11):3944-3962. doi: 10.1007/s11695-024-07489-7. Epub 2024 Oct 14.
3
Medium and Long-Term Weight Loss After Revisional Bariatric Surgery: A Systematic Review and Meta-Analysis.
修正性减重手术后的中长期减重效果:系统评价和荟萃分析。
Obes Surg. 2024 May;34(5):1917-1928. doi: 10.1007/s11695-024-07206-4. Epub 2024 Apr 4.